Your shopping cart is currently empty

LX2932 is an oral analog of LX2931 and acts as a modulator of the S1P/S1PR signaling pathway. It effectively decreases the number of circulating lymphocytes in a dose-dependent manner. Additionally, LX2932 has been shown to ameliorate collagen-induced arthritis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | LX2932 is an oral analog of LX2931 and acts as a modulator of the S1P/S1PR signaling pathway. It effectively decreases the number of circulating lymphocytes in a dose-dependent manner. Additionally, LX2932 has been shown to ameliorate collagen-induced arthritis. |
| Molecular Weight | 255.23 |
| Formula | C10H13N3O5 |
| Cas No. | 1055027-48-9 |
| Smiles | [C@@H]([C@@H]([C@@H](CO)O)O)(O)C=1NC(=NC1)C=2C=CON2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.